XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Interim Consolidated Statement Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net
Noncontrolling Interests
Treasury Stock, Common
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity   $ 0 $ 333 $ 9,677 $ (329)   $ (5,492)
Balance as of the beginning of the period (in shares) at Dec. 31, 2021   108,023,735         61,736,289
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax     23        
Purchases of treasury stock (in shares) 0            
Issuance of treasury stock under stock plans             $ 0
Issuance of treasury stock under stock plans (in shares)             (32,243)
Stock awards (in shares)   363,004          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation $ 1,127     1,127      
Common stock dividends       (220)      
Other comprehensive income (loss), net of tax (169)       (169)    
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2021           $ 348  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 6         6  
Distributions/dividends to noncontrolling interests           (10)  
Balance as of the end of the period, noncontrolling interest at Sep. 30, 2022           344  
Balance as of the end of the period (in shares) at Sep. 30, 2022   108,386,739         61,704,046
Balance as of the end of the period at Sep. 30, 2022 5,294            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity   $ 0 344 10,466 (438)   $ (5,492)
Balance as of the beginning of the period (in shares) at Jun. 30, 2022   108,346,035         61,704,046
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax     12        
Issuance of treasury stock under stock plans             $ 0
Issuance of treasury stock under stock plans (in shares)             0
Stock awards (in shares)   40,704          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation 191     191      
Common stock dividends       (73)      
Other comprehensive income (loss), net of tax (60)       (60)    
Balance as of the beginning of the period, noncontrolling interest at Jun. 30, 2022           345  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 2         2  
Distributions/dividends to noncontrolling interests           (3)  
Balance as of the end of the period, noncontrolling interest at Sep. 30, 2022           344  
Balance as of the end of the period (in shares) at Sep. 30, 2022   108,386,739         61,704,046
Balance as of the end of the period at Sep. 30, 2022 5,294            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity 4,950 $ 0 356 10,584 (498)   $ (5,492)
Celanese Corporation stockholders' equity 5,637 $ 0 372 11,274 (518)   $ (5,491)
Balance as of the beginning of the period (in shares) at Dec. 31, 2022   108,473,932         61,661,493
Balance as of the beginning of the period at Dec. 31, 2022 $ 6,105            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax     14        
Purchases of treasury stock (in shares) 0            
Issuance of treasury stock under stock plans             $ 1
Issuance of treasury stock under stock plans (in shares)             (50,092)
Stock awards (in shares)   380,106          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation $ 1,262     1,262      
Common stock dividends       (228)      
Other comprehensive income (loss), net of tax (195)       (195)    
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2022 468         468  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 1         1  
Distributions/dividends to noncontrolling interests           (11)  
Balance as of the end of the period, noncontrolling interest at Sep. 30, 2023 458         458  
Balance as of the end of the period (in shares) at Sep. 30, 2023   108,854,038         61,611,401
Balance as of the end of the period at Sep. 30, 2023 6,949            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity   $ 0 383 11,433 (702)   $ (5,490)
Balance as of the beginning of the period (in shares) at Jun. 30, 2023   108,847,435         61,611,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax     3        
Issuance of treasury stock under stock plans             $ 0
Issuance of treasury stock under stock plans (in shares)             0
Stock awards (in shares)   6,603          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation 951     951      
Common stock dividends       (76)      
Other comprehensive income (loss), net of tax (11)       (11)    
Balance as of the beginning of the period, noncontrolling interest at Jun. 30, 2023           464  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests (2)         (2)  
Distributions/dividends to noncontrolling interests           (4)  
Balance as of the end of the period, noncontrolling interest at Sep. 30, 2023 458         $ 458  
Balance as of the end of the period (in shares) at Sep. 30, 2023   108,854,038         61,611,401
Balance as of the end of the period at Sep. 30, 2023 6,949            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity $ 6,491 $ 0 $ 386 $ 12,308 $ (713)   $ (5,490)